Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Amr Radwan

Regeneron Pharmaceuticals

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (1)

Stephanie Christenson

Associate Professor in Residence

University of California, San Francisco

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amr Radwan

Research Interests

Explore related searches

Articles (11)

Burden of eosinophilic esophagitis in adult and adolescent patients: results from a real-world analysis

A Real-World Study of Cumulative Steroid Burden Among Patients with Eosinophilic Esophagitis in the United States

Baseline disease characteristics by surgery history among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the global AROMA registry

Dupilumab Efficacy and Safety in Children With Moderate to Severe Asthma and High Blood Eosinophils: A Post Hoc Analysis of VOYAGE

Current Smoker: A Clinical COPD Phenotype Affecting Disease Progression and Response to Therapy

Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the phase 3, randomized, placebo-controlled, LIBERTY EoE TREET trial

Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma

Study design of the phase IV, randomized, placebo-controlled REMOdeling with Dupilumab in Eosinophilic esophagitis Long-term (REMODEL) trial

Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry

Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)

The Emerging Role of Alarmin-Targeting Biologics in the Treatment of Patients With COPD

Collaborators (1)

Stephanie Christenson

Make your next move.